Module 4 of 8

Clinical Trial Intelligence

Enter trials for the target asset, competitive pipeline, and on-market products. Use NCT IDs to auto-fill from ClinicalTrials.gov.

Target Asset Trials

Clinical trials for the drug(s) of interest at the target company.

Auto-fill from ClinicalTrials.gov (NCT ID)

Drug / Asset Name *

Indication

Phase

Status

Primary Endpoint

Key Findings / Notes

Competitive Threat Matrix

AI analysis of the target asset's competitive positioning across all three trial panels.

Add at least one trial above to enable the competitive threat analysis.